Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4531

1.

Sequential molecular and cytologic analyses provides a complementary approach to the diagnosis of pancreatic cystic lesions: a decade of clinical practice.

Sakhdari A, Moghaddam PA, Pejchal M, Cosar EF, Hutchinson L.

J Am Soc Cytopathol. 2019 Oct 14. pii: S2213-2945(19)30302-3. doi: 10.1016/j.jasc.2019.09.002. [Epub ahead of print]

PMID:
31711852
2.

[Clinical Features of Von-Hippel-Lindau Syndrome and Its Ultrasonographic Diagnosis of Abdominal Mass].

Zhao RN, Zhang B, Jiang YX.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):658-662. doi: 10.3881/j.issn.1000-503X.10939. Chinese.

3.

Hypoxia drives glucose transporter 3 expression through HIF-mediated induction of the long non-coding RNA NICI.

Lauer V, Grampp S, Platt J, Lafleur V, Lombardi O, Choudhry H, Kranz F, Hartmann A, Wullich B, Yamamoto A, Coleman ML, Ratcliffe PJ, Mole DR, Schödel J.

J Biol Chem. 2019 Nov 5. pii: jbc.RA119.009827. doi: 10.1074/jbc.RA119.009827. [Epub ahead of print]

4.

Obstructive azoospermia secondary to bilateral epididymal cystadenomas in a patient with von Hippel-Lindau.

Gomella PT, Shin P, Srinivasan R, Linehan WM, Ball MW.

Urol Case Rep. 2019 May 29;27:100922. doi: 10.1016/j.eucr.2019.100922. eCollection 2019 Nov.

5.

Ferritin is regulated by a neuro-intestinal axis in the nematode Caenorhabditis elegans.

Romero-Afrima L, Zelmanovich V, Abergel Z, Zuckerman B, Shaked M, Abergel R, Livshits L, Smith Y, Gross E.

Redox Biol. 2019 Oct 25;28:101359. doi: 10.1016/j.redox.2019.101359. [Epub ahead of print]

6.

Role of alternative splicing signatures in the prognosis of glioblastoma.

Xie ZC, Wu HY, Dang YW, Chen G.

Cancer Med. 2019 Nov 1. doi: 10.1002/cam4.2666. [Epub ahead of print]

7.

Clear cell chondrosarcoma in Von Hippel-Lindau disease.

Dreijerink KMA, van Leeuwaarde RS, Hackeng WM, Giles RH, de Leng WWJ, Jutte PC, Suurmeijer AJH, van Nesselrooij BPM, Brosens LAA.

Fam Cancer. 2019 Oct 31. doi: 10.1007/s10689-019-00149-1. [Epub ahead of print]

PMID:
31673890
8.

A novel strategy to block mitotic progression for targeted therapy.

Chi JJ, Li H, Zhou Z, Izquierdo-Ferrer J, Xue Y, Wavelet CM, Schiltz GE, Zhang B, Cristofanilli M, Lu X, Bahar I, Wan Y.

EBioMedicine. 2019 Oct 25. pii: S2352-3964(19)30677-2. doi: 10.1016/j.ebiom.2019.10.013. [Epub ahead of print]

9.

Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.

Albattal S, Alswailem M, Moria Y, Al-Hindi H, Dasouki M, Abouelhoda M, Alkhail HA, Alsuhaibani E, Alzahrani AS.

Oncotarget. 2019 Oct 15;10(57):5919-5931. doi: 10.18632/oncotarget.27194. eCollection 2019 Oct 15.

10.

Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.

Schuhmacher P, Kim E, Hahn F, Sekula P, Jilg CA, Leiber C, Neumann HP, Schultze-Seemann W, Walz G, Zschiedrich S.

Orphanet J Rare Dis. 2019 Oct 28;14(1):235. doi: 10.1186/s13023-019-1206-2.

11.

The lesbian, gay, bisexual and transgender movement: A systematic review with meta-analysis.

Almeida EPO, Rolim Neto ML.

Int J Soc Psychiatry. 2019 Oct 29:20764019882966. doi: 10.1177/0020764019882966. [Epub ahead of print]

PMID:
31659921
12.

Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.

Somorácz Á, Kuthi L, Micsik T, Jenei A, Hajdu A, Vrabély B, Rásó E, Sápi Z, Bajory Z, Kulka J, Iványi B.

Pathol Oncol Res. 2019 Oct 26. doi: 10.1007/s12253-019-00757-3. [Epub ahead of print]

PMID:
31656019
13.

Overexpression of steroid sulfotransferase genes is associated with worsened prognosis and with immune exclusion in clear cell-renal cell carcinoma.

Li Y, Ding Q, Xiong Z, Wen H, Feng C.

Aging (Albany NY). 2019 Oct 27;11(20):9209-9219. doi: 10.18632/aging.102392. Epub 2019 Oct 27.

14.

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.

Nassar AH, Hamieh L, Gray KP, Thorner AR, Fay AP, Lasseter KD, Abou Alaiwi S, Nuzzo PV, Flippot R, Krajewski KM, Signoretti S, Choueiri TK, Kwiatkowski DJ.

Mol Cancer Ther. 2019 Oct 25. pii: molcanther.0642.2019. doi: 10.1158/1535-7163.MCT-19-0642. [Epub ahead of print]

PMID:
31653662
15.

Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.

Zhou B, Wang J, Liu S, Peng X, Hong B, Zhou J, Ma K, Zhang J, Cai L, Gong K.

Front Oncol. 2019 Oct 9;9:1037. doi: 10.3389/fonc.2019.01037. eCollection 2019.

16.

Targeting Transient Receptor Potential Channels by MicroRNAs Drives Tumor Development and Progression.

Santoni G, Morelli MB, Santoni M, Nabissi M, Marinelli O, Amantini C.

Adv Exp Med Biol. 2020;1131:605-623. doi: 10.1007/978-3-030-12457-1_24. Review.

PMID:
31646527
17.

Is ultra wide-field retinal imaging alone appropriate for retinal angioma screening in lower risk subjects attending Von Hippel-Lindau (VHL) clinics?

Mansfield Smith S, Makam R, Sullivan L, Sandford R, Allen L.

Ophthalmic Genet. 2019 Oct 22:1-4. doi: 10.1080/13816810.2019.1678177. [Epub ahead of print]

PMID:
31638449
18.

Steroid Receptor Coactivator-1 Expression in Pheochromocytoma: Clinicopathologic Correlation and Potential Diagnostic Pitfall.

Xiong MJ, Osunkoya AO.

Appl Immunohistochem Mol Morphol. 2019 Oct 17. doi: 10.1097/PAI.0000000000000815. [Epub ahead of print]

PMID:
31633491
19.

Synthetic lethality between loss of CDK4/6 activity and VHL inactivation.

Allison SJ.

Nat Rev Nephrol. 2019 Oct 18. doi: 10.1038/s41581-019-0225-5. [Epub ahead of print] No abstract available.

PMID:
31628435
20.

VHL Expression in Kidney Cancer: Relation to Metastasis Development, Transcription and Growth Factors and Component of Akt/m-TOR Signaling Pathway.

Spirina LV, Kondakova IV, Yurmazov ZA, Usynin EA, Slonimskaya EM, Lushnikova NA, Podnebesnova DV.

Bull Exp Biol Med. 2019 Oct 17. doi: 10.1007/s10517-019-04596-9. [Epub ahead of print]

PMID:
31625068

Supplemental Content

Support Center